C90.0 ICD 10 Code is a non-billable and non-specific code and should not be used to indicate a diagnosis for reimbursement purposes. There are other codes below it with greater level of diagnosis detail. The 2023 edition of the American ICD-10-CM code became effective on October 1, 2022.

Type 1 excludes for C90.0 ICD 10 code
  • solitary myeloma (C90.3-)
  • solitary plasmactyoma (C90.3-)

Codes
Terms applicables to C90.0 ICD 10 code
Possible back-references that may be applicable or related to C90.0 ICD10 Code:

Present On Admission (POA Exempt)

C90.0 ICD 10 code is considered exempt from POA reporting

Clinical information about C90.0 ICD 10 code

Multiple myeloma is a cancer that begins in plasma cells, a type of white blood cell. These cells are part of your immune system, which helps protect the body from germs and other harmful substances. In time, myeloma cells collect in the bone marrow and in the solid parts of bones.

No one knows the exact causes of multiple myeloma, but it is more common in older people and African Americans. It can run in families. Common symptoms may include:

  • Bone pain, often in the back or ribs
  • Fractures (broken bones)
  • Weakness or fatigue
  • Weight loss
  • Frequent infections and fevers
  • Feeling very thirsty
  • Frequent urination

Doctors diagnose multiple myeloma using lab tests, imaging tests, and a bone marrow biopsy. Your treatment depends on how advanced the disease is and whether you have symptoms. If you have no symptoms, you may not need treatment right away. If you have symptoms, you may have chemotherapy, stem cell transplantation, radiation, or targeted therapy. Targeted therapy uses drugs or other substances that attack specific cancer cells with less harm to normal cells.

NIH: National Cancer Institute

The information in this box was provided by MedlinePlus.gov